文献速递肝病消化道肿瘤与早癌

单细胞DNA测序揭示肝细胞癌的间断性与渐进性克隆演化

Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma.
PubMed 文献 · Gastroenterology · 2021-09-02

该研究对10例肝细胞癌(HCC)患者的1275个细胞行单细胞DNA测序,并对另1例356个细胞行倍性分辨的单细胞DNA测序、对另3例27344个细胞行单细胞RNA测序。结果显示拷贝数改变(CNA)积累遵循间断期后接渐进期的双相演化模型,渐进期延长者瘤内异质性更高、无病生存更差,CAD高表达与快速成瘤和生存降低相关。

要点

  • HCC的CNA积累呈间断期后接渐进期的双相演化模型。
  • 渐进期延长的患者瘤内异质性更高且无病生存更差。
  • CAD高表达与快速成瘤和生存降低相关,或为早期复发标志物。

核心结论

  • HCC的拷贝数改变积累遵循间断期后接渐进期的双相演化模型。
  • 渐进期延长的HCC瘤内异质性更高且无病生存更差。
  • CAD高表达与快速成瘤和生存降低相关,是HCC早期复发的潜在生物标志物。
  • 倍性分辨的单细胞DNA测序支持多倍体HCC细胞起源于二倍体肿瘤细胞。

研究设计与样本

  • 对10例HCC患者的1275个细胞行单细胞DNA测序(scDNA-seq)。
  • 对另1例患者的356个细胞行倍性分辨的单细胞DNA测序。
  • 对另3例患者的27344个细胞行单细胞RNA测序。
  • 比较三种统计拟合模型以研究CNA积累模式。
  • 整合17例HCC患者的bulk RNA测序、1196个已发表肝肿瘤数据集和202个HCC肿瘤的免疫组化染色。

主要发现

  • 肿瘤细胞被分为整倍体、假整倍体和异倍体三个亚群。
  • CNA积累遵循间断期后接渐进期的双相演化模型。
  • 渐进期延长的患者瘤内异质性更高且无病生存更差。
  • CAD(参与嘧啶合成的基因)高表达与快速成瘤和生存降低相关。
  • 倍性分辨的单细胞DNA测序揭示二倍体和多倍体异倍体细胞的共同克隆起源,提示多倍体肿瘤细胞由二倍体肿瘤细胞全基因组加倍产生。

关键数值与推荐

  • 双相拷贝数演化模型在单细胞RNA测序数据和已发表的其他癌种scDNA-seq数据中得到验证。

临床怎么用

  • CAD高表达可作为HCC早期复发的潜在生物标志物。
  • 渐进期延长的HCC患者瘤内异质性更高且无病生存更差,提示需更密切随访。
  • 多倍体HCC细胞起源于二倍体肿瘤细胞,支持二倍体起源假说。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Copy number alterations (CNAs), elicited by genome instability, are a major source of intratumor heterogeneity. How CNAs evolve in hepatocellular carcinoma (HCC) remains unknown. METHODS: We performed single-cell DNA sequencing (scDNA-seq) on 1275 cells isolated from 10 patients with HCC, ploidy-resolved scDNA-seq on 356 cells from 1 additional patient, and single-cell RNA sequencing on 27,344 cells from 3 additional patients. Three statistical fitting models were compared to investigate the CNA accumulation pattern. RESULTS: Cells in the tumor were categorized into the following 3 subpopulations: euploid, pseudoeuploid, and aneuploid. Our scDNA-seq analysis revealed that CNA accumulation followed a dual-phase copy number evolution model, that is, a punctuated phase followed by a gradual phase. Patients who exhibited prolonged gradual phase showed higher intratumor heterogeneity and worse disease-free survival. Integrating bulk RNA sequencing of 17 patients with HCC, published datasets of 1196 liver tumors, and immunohistochemical staining of 202 HCC tumors, we found that high expression of CAD, a gene involved in pyrimidine synthesis, was correlated with rapid tumorigenesis and reduced survival. The dual-phase copy number evolution model was validated by our single-cell RNA sequencing data and published scDNA-seq datasets of other cancer types. Furthermore, ploidy-resolved scDNA-seq revealed the common clonal origin of diploid- and polyploid-aneuploid cells, suggesting that polyploid tumor cells were generated by whole genome doubling of diploid tumor cells. CONCLUSIONS: Our work revealed a novel dual-phase copy number evolution model, showed HCC with longer gradual phase was more severe, identified CAD as a promising biomarker for early recurrence of HCC, and supported the diploid origin of polyploid HCC.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Guo L, Yi X, Chen L, et al. Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma. Gastroenterology. 2021. PMID: 34481846. doi:10.1053/j.gastro.2021.08.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。